Investors Guide (December 2025)

Investors Guide

(Date of Release: Jan 21, 2026)

Japan Lifeline Co., Ltd.

TSE Prime: 7575

Unauthorized reproduction prohibited.

Copyright © 2026 Japan Lifeline Co., Ltd. All rights reserved.

• Japan Lifeline established a sustainable growth model in "cardiac & high-spec" medical devices

• Driving global medtech transformation, fueled by robust domestic earnings

  Japan Global

  Head winds

  Medical fee revisions

  Neutral

  Head

  winds

  
  
  

  • Deflationary pressure

  • Increased costs

    Weak Yen

Cardiac care x high-spec medical devices

Hybrid business model:

Niche-Leading Connoisseur

Manufacturer distributor

Growth investment

Leveraging stable domestic earnings to enter growth markets

Untapped markets

FY2025 International sales mix 2%

External environ ments

Strong tail winds

Head winds

Risk mitigation

Sales price increase

Increase in heart disease

Securing a new product pipeline

Highly profitable/

Stable FCF

Long-term market contraction

High dividends

in the long-term

2

Intl. growth outpacing domestic market contraction

Approx.200,000/year

1. Business Highlights p5
2. Strategic Highlights p21
3. Financial Highlights p28

1. Product Portfolio p34

2. Market Data Supplement p50

3. Business Topics Supplement p56

   
   
   

4. Medium-Term Plan Supplement p67

5. Capital Policy & Share Price p74

6. Investor FAQ p83

7. Disease Background p91

8. Appendix p113

1. Business Highlights p5

2. Strategic Highlights p21

3. Financial Highlights p28

1. Product Portfolio p34

2. Market Data Supplement p50

3. Business Topics Supplement p56

   
   
   

4. Medium-Term Plan Supplement p67

5. Capital Policy & Share Price p74

6. Investor FAQ p83

7. Disease Background p91

8. Appendix p113